124 related articles for article (PubMed ID: 8030940)
1. Nucleation of amyloidogenesis in infectious and noninfectious amyloidoses of brain.
Gajdusek DC
Ann N Y Acad Sci; 1994 Jun; 724():173-90. PubMed ID: 8030940
[No Abstract] [Full Text] [Related]
2. Human brain amyloidoses.
Gambetti P; Russo C
Nephrol Dial Transplant; 1998; 13 Suppl 7():33-40. PubMed ID: 9870435
[No Abstract] [Full Text] [Related]
3. Amyloidosis in prion diseases and cells involved in PrP fibrillogenesis.
Wisniewski HM; Wegiel J; Kozielski R
Ann N Y Acad Sci; 1994 Jun; 724():191-209. PubMed ID: 7913300
[No Abstract] [Full Text] [Related]
4. Amyloid and prions: some biochemical investigations of cerebral amyloidosis in mice.
Hope J; Kirby L
Folia Neuropathol; 2012; 50(1):13-9. PubMed ID: 22505360
[TBL] [Abstract][Full Text] [Related]
5. Prion-like aggregates: infectious agents in human disease.
Westermark GT; Westermark P
Trends Mol Med; 2010 Nov; 16(11):501-7. PubMed ID: 20870462
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of accumulation of prion amyloid in the CNS in experimental amyotrophic leukospongiosis].
Poleshchuk NN; Votiakov VI; Il'kevich IuG; Dubovskaia GP; Kolomiets ND
Biull Eksp Biol Med; 1991 Dec; 112(12):640-3. PubMed ID: 1777639
[TBL] [Abstract][Full Text] [Related]
7. The new biology of spongiform encephalopathy: infectious amyloidoses with a genetic twist.
Brown P; Goldfarb LG; Gajdusek DC
Lancet; 1991 Apr; 337(8748):1019-22. PubMed ID: 1673176
[No Abstract] [Full Text] [Related]
8. Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis.
Green NS; Foss TR; Kelly JW
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14545-50. PubMed ID: 16195386
[TBL] [Abstract][Full Text] [Related]
9. Cerebral amyloidosis: amyloid subunits, mutants and phenotypes.
Rostagno A; Holton JL; Lashley T; Revesz T; Ghiso J
Cell Mol Life Sci; 2010 Feb; 67(4):581-600. PubMed ID: 19898742
[TBL] [Abstract][Full Text] [Related]
10. Genetic control of nucleation and polymerization of host precursors to infectious amyloids in the transmissible amyloidoses of brain.
Gajdusek DC
Br Med Bull; 1993 Oct; 49(4):913-31. PubMed ID: 8137135
[No Abstract] [Full Text] [Related]
11. Hidden amyloidoses.
Diringer H
Exp Clin Immunogenet; 1992; 9(4):212-29. PubMed ID: 1364008
[TBL] [Abstract][Full Text] [Related]
12. Proteomic characterization of amyloid deposits in transthyretin amyloidosis associated with various mutations.
Valentini V; Lavatelli F; Obici L; Donadei S; Perlini S; Palladini G; Merlini G
Amyloid; 2011 Jun; 18 Suppl 1():61-3. PubMed ID: 21838434
[No Abstract] [Full Text] [Related]
13. An animal model of vascular amyloidosis.
Ghiso J; Wisniewski T
Nat Neurosci; 2004 Sep; 7(9):902-4. PubMed ID: 15332087
[No Abstract] [Full Text] [Related]
14. [Yeast prions as a model of neurodegenerative infectious amyloidoses in humans].
Inge-Vechtomov SG
Ontogenez; 2011; 42(5):337-45. PubMed ID: 22145302
[TBL] [Abstract][Full Text] [Related]
15. Virus-induced amyloidoses.
Diringer H
Behring Inst Mitt; 1991 Jul; (89):146-52. PubMed ID: 1930093
[TBL] [Abstract][Full Text] [Related]
16. [Classification of amyloidosis].
Misumi Y; Ando Y
Brain Nerve; 2014 Jul; 66(7):731-7. PubMed ID: 24998818
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the Amyloidogenesis of Transthyretin by Natural Products and Synthetic Compounds.
Yokoyama T; Mizuguchi M
Biol Pharm Bull; 2018; 41(7):979-984. PubMed ID: 29962408
[TBL] [Abstract][Full Text] [Related]
18. Amyloid plaques in Creutzfeldt-Jakob disease stain with prion protein antibodies.
Kitamoto T; Tateishi J; Tashima T; Takeshita I; Barry RA; DeArmond SJ; Prusiner SB
Ann Neurol; 1986 Aug; 20(2):204-8. PubMed ID: 3092727
[TBL] [Abstract][Full Text] [Related]
19. Unconventional slow viruses, amyloidosis, and dementias.
Diringer H
Lancet; 1985 Sep; 2(8456):661-2. PubMed ID: 2863647
[No Abstract] [Full Text] [Related]
20. [What causes Abeta amyloidosis in the brain?].
Matsubara E; Yanagisawa K
No To Shinkei; 2005 Oct; 57(10):829-38. PubMed ID: 16277228
[No Abstract] [Full Text] [Related]
[Next] [New Search]
